Friday, April 11, 2014
In this panel moderated by Daniel Carpenter, Peggy Orenstein, C. Noel Bairey Merz, and Barron Lerner consider whether gender drives commercial and public research in particular diseases, the politics of health campaigns, the formulation and analysis of clinical trials, and the role of the marketplace and private funding in addressing diseases that affect women and men differently.